Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments

January 24, 2020 admin Trading Ideas Comments Off on Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments

Many other members of Big Pharma spent more on dividends and stock buybacks, a strategy some view as shortsighted Continue reading… …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.